| scholarly article | Q13442814 |
| P2093 | author name string | Parker TG | |
| Zeller M | |||
| Liew CC | |||
| Rakowski H | |||
| Sole MJ | |||
| Liew JC | |||
| Wigle ED | |||
| Woo A | |||
| Zhao MS | |||
| P2860 | cites work | Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1 | Q69792543 |
| Angiotensin-I Converting Enzyme Genotypes and Left Ventricular Hypertrophy in Patients With Hypertrophic Cardiomyopathy | Q72050276 | ||
| Variants of trophic factors and expression of cardiac hypertrophy in patients with hypertrophic cardiomyopathy | Q73288500 | ||
| Temporal repolarization lability in hypertrophic cardiomyopathy caused by beta-myosin heavy-chain gene mutations | Q73566746 | ||
| Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations | Q74353552 | ||
| Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: hypertrophic cardiomyopathy, long-QT syndrome, and marfan syndrome : A statement for healthcare professionals from the | Q77369184 | ||
| Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly | Q24292234 | ||
| Characterization of human cardiac myosin heavy chain genes | Q24615031 | ||
| Three-dimensional structure of myosin subfragment-1: a molecular motor | Q27731679 | ||
| Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy | Q28141697 | ||
| The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms | Q28203734 | ||
| Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy | Q28216997 | ||
| Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy | Q28236892 | ||
| Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy | Q28268916 | ||
| The Genetic Basis for Cardiomyopathy | Q29300961 | ||
| Functional consequences of mutations in the smooth muscle myosin heavy chain at sites implicated in familial hypertrophic cardiomyopathy | Q30884033 | ||
| Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. | Q33145986 | ||
| Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation | Q33153444 | ||
| Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations | Q33174333 | ||
| Age and body surface area related normal upper and lower limits of M mode echocardiographic measurements and left ventricular volume and mass from infancy to early adulthood | Q33614115 | ||
| Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy | Q33806181 | ||
| The molecular genetic basis for hypertrophic cardiomyopathy | Q33939892 | ||
| Tissue Doppler imaging consistently detects myocardial contraction and relaxation abnormalities, irrespective of cardiac hypertrophy, in a transgenic rabbit model of human hypertrophic cardiomyopathy | Q34008230 | ||
| Hypertrophic cardiomyopathy: a systematic review | Q34117625 | ||
| The molecular genetics of hypertrophic cardiomyopathy: prognostic implications | Q34166230 | ||
| Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy | Q34386835 | ||
| New concepts in hypertrophic cardiomyopathies, part I. | Q34416641 | ||
| Cardiomyopathy: The diagnosis of hypertrophic cardiomyopathy | Q34441506 | ||
| Complete sequence and organization of the human cardiac beta-myosin heavy chain gene | Q35846655 | ||
| Echocardiographic and Doppler assessment of hypertrophic cardiomyopathy | Q39490561 | ||
| Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review | Q39614414 | ||
| Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families | Q41342233 | ||
| Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy | Q44319774 | ||
| Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective | Q47886356 | ||
| Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population. | Q50944752 | ||
| The cardiac beta-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population. | Q52906642 | ||
| Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy. | Q52962652 | ||
| Genotype-phenotype analysis in four families with mutations in β-myosin heavy chain gene responsible for familial hypertrophic cardiomyopathy | Q57907368 | ||
| Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy | Q58819293 | ||
| A point-score system for the ECG diagnosis of left ventricular hypertrophy | Q68411478 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypertrophic cardiomyopathy | Q1364270 |
| P304 | page(s) | 1179-1185 | |
| P577 | publication date | 2003-10-01 | |
| P1433 | published in | Heart | Q856338 |
| P1476 | title | Mutations of the beta myosin heavy chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosis | |
| P478 | volume | 89 |
| Q91359304 | A novel MYBPC3 c.2737+1 (IVS26) G>T mutation responsible for high-risk hypertrophic cardiomyopathy |
| Q46128365 | A novel mutation of the beta myosin heavy chain gene responsible for familial hypertrophic cardiomyopathy. |
| Q37191627 | Bioinformatics assessment of beta-myosin mutations reveals myosin's high sensitivity to mutations |
| Q41936884 | Clinical Genetic Testing for the Cardiomyopathies and Arrhythmias: A Systematic Framework for Establishing Clinical Validity and Addressing Genotypic and Phenotypic Heterogeneity |
| Q27712437 | Cryo-EM structure of a human cytoplasmic actomyosin complex at near-atomic resolution |
| Q43014048 | From malignant mutations to malignant domains: the continuing search for prognostic significance in the mutant genes causing hypertrophic cardiomyopathy |
| Q38125765 | Genetic biomarkers in hypertrophic cardiomyopathy. |
| Q36712985 | Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing |
| Q34999606 | Genetics and clinical destiny: improving care in hypertrophic cardiomyopathy |
| Q41993268 | Hypertrophic cardiomyopathy: from mutation to functional analysis of defective protein |
| Q37070209 | Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression |
| Q37714017 | Malignant and benign mutations in familial cardiomyopathies: insights into mutations linked to complex cardiovascular phenotypes. |
| Q34359106 | Mendelian-inherited heart disease: a gateway to understanding mechanisms in heart disease Update on work done at the University of Stellenbosch |
| Q30388756 | Multidimensional structure-function relationships in human β-cardiac myosin from population-scale genetic variation |
| Q34474908 | Narrative review: harnessing molecular genetics for the diagnosis and management of hypertrophic cardiomyopathy |
| Q33312381 | Noncompaction of the ventricular myocardium is associated with a de novo mutation in the beta-myosin heavy chain gene |
| Q35792948 | Phenotype and prognostic correlations of the converter region mutations affecting the β myosin heavy chain |
| Q24300812 | Prevalence of cardiac beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy |
| Q33620883 | Recessive myosin myopathy with external ophthalmoplegia associated with MYH2 mutations |
| Q35436364 | Survival and clinical behavior of hypertrophic cardiomyopathy in a latin american cohort in contrast to cohorts from the developed world |
| Q37130043 | Targeted sequence capture and GS-FLX Titanium sequencing of 23 hypertrophic and dilated cardiomyopathy genes: implementation into diagnostics |
| Q58565497 | The genetics of hypertrophic cardiomyopathy |
| Q36056126 | The structural effects of mutations can aid in differential phenotype prediction of beta-myosin heavy chain (Myosin-7) missense variants. |
| Q46888862 | Troponin T and beta-myosin mutations have distinct cardiac functional effects in hypertrophic cardiomyopathy patients without hypertrophy |
| Q81000083 | Worse prognosis with gene mutations of beta-myosin heavy chain than myosin-binding protein C in Chinese patients with hypertrophic cardiomyopathy |
| Q47877602 | Yield of genetic testing in hypertrophic cardiomyopathy |
| Q33864019 | β-Myosin heavy chain variant Val606Met causes very mild hypertrophic cardiomyopathy in mice, but exacerbates HCM phenotypes in mice carrying other HCM mutations |
Search more.